Jim Simons Lucid Diagnostics Inc. Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 243,279 shares of LUCD stock, worth $243,279. This represents 0.0% of its overall portfolio holdings.
Number of Shares
243,279
Previous 459,065
47.01%
Holding current value
$243,279
Previous $684,000
59.21%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LUCD
# of Institutions
69Shares Held
15.2MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.13MShares$4.13 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA2.73MShares$2.73 Million0.21% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL1.89MShares$1.89 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.58MShares$1.58 Million0.0% of portfolio
-
State Street Corp Boston, MA623KShares$623,0680.0% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $38.6M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...